The Visionary's Audacious Forecast
Dr. Devi Shetty, the founder of Narayana Health, has made a bold prediction: within the next five to seven years, India will become the first country to separate the quality of healthcare from a person's wealth. This isn't just wishful thinking; it's
a forecast from a man who revolutionised cardiac care by applying economies of scale to medicine. His philosophy has been likened to that of Henry Ford, using high-volume, assembly-line efficiency to dramatically lower costs. At his hospitals, the average cost of open-heart surgery was brought down to under $2,000 (around ₹1.6 lakhs), a procedure that can cost over $100,000 in the United States. His core belief is that no solution is a real solution if it isn't affordable. Dr. Shetty's latest forecast doesn't rely on charity, but on a systemic shift: the widespread adoption of health insurance. He argues that as insurance becomes more accessible, it will bridge the affordability gap for the 70% of Indians who currently lack the ready cash for major procedures.
Reality Check: A Tale of Two Tiers
While Dr. Shetty's vision is inspiring, the current landscape of private healthcare costs presents a more complex picture. There's a stark difference in expenses between metropolitan and smaller cities. According to data from insurers, the indicative average cost of treatment in a Tier 1 city like Mumbai, Delhi, or Bengaluru can be around ₹2,20,000, more than double the average of ₹95,000 in a Tier 2 city. This variation plays out across specific procedures. For an angioplasty, a common cardiac intervention, patients in private hospitals can expect a bill ranging anywhere from ₹1.5 lakh to ₹4.5 lakh. A closer look at city-specific averages reveals Mumbai as one of the most expensive at roughly ₹2.19 lakh for the procedure, while Kolkata is considerably lower at ₹1.1 lakh. Some estimates for Tier 1 cities place the cost for angioplasty with a stent even higher, approaching ₹4.8 lakh.
Decoding the Hospital Bill
The massive range in angioplasty costs, from ₹1.5 lakh to over ₹4.5 lakh, highlights a crucial point. While the government has stepped in to control the price of essential hardware—capping the price of a drug-eluting stent at a non-negotiable ₹39,186 (plus GST) since April 2026—this is often just one component of a much larger bill. The final amount a patient pays is driven by a host of other unregulated factors: the surgeon’s fees, operating theatre charges, the category of room chosen, and the number of days spent in the hospital. Hospitals in prime metro locations face higher real estate and operational costs, which are invariably passed on to the patient. This is where the model of a general multi-specialty hospital diverges sharply from Dr. Shetty’s high-volume, specialised centres. Most private hospitals simply do not have the massive patient numbers for a single procedure that would allow them to leverage the same economies of scale that Narayana Health is famous for.
Can the Gap Be Bridged?
This brings us back to Dr. Shetty’s forecast. How can his vision of affordable care for all become a nationwide reality? The key, he believes, lies in a robust insurance system. He argues that the only missing link is the payment mechanism, as India has been rapidly increasing its number of doctors and hospital beds. He even proposes an innovative solution where hospitals themselves become insurance providers, a move he believes would align the interests of patients and providers and reduce the friction that often leads to inflated costs. The expansion of government schemes like Ayushman Bharat and the increasing penetration of private insurance are the engines expected to drive this change. The idea is that with sufficient coverage, a family could be protected from catastrophic expenses. If these financial mechanisms become as widespread and efficient as Dr. Shetty predicts, the dream of disconnecting healthcare from wealth may indeed move from a single hospital's mission to a national achievement.
















